Timucin Avsar
Timucin Avsar
Bahcesehir University, School of Medicine
med.bau.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
VE Clark, EZ Erson-Omay, A Serin, J Yin, J Cotney, K Özduman, T Avşar, ...
Science 339 (6123), 1077-1080, 2013
4722013
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study
J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...
Multiple Sclerosis Journal 21 (8), 1013-1024, 2015
2072015
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
G Disanto, R Adiutori, R Dobson, V Martinelli, G Dalla Costa, T Runia, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (2), 126-129, 2016
822016
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis
LM Villar, B Casanova, N Ouamara, M Comabella, F Jalili, D Leppert, ...
Annals of neurology 76 (2), 231-240, 2014
562014
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis
T Avsar, D Korkmaz, M Tütüncü, NO Demirci, S Saip, M Kamasak, A Siva, ...
Multiple Sclerosis Journal 18 (8), 1081-1091, 2012
442012
Temporal expression analysis of angiogenesis-related genes in brain development
A Özkan, A Biçer, T Avşar, A Şeker, ZO Toktaş, SU Bozkurt, AN Başak, ...
Vascular Cell 4 (1), 16, 2012
142012
Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and …
S Durdagi, B Aksoydan, I Erol, I Kantarcioglu, Y Ergun, G Bulut, M Acar, ...
European Journal of Medicinal Chemistry 145, 273-290, 2018
112018
General Methods in Biomarker Research and Their Applications
VR Preedy, VB Patel
Springer Netherlands, 2015
112015
Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis
O Karal-Yilmaz, A Ozkan, E Akgun, M Kukut, K Baysal, T Avsar, T Kilic
Journal of Materials Science: Materials in Medicine 24 (1), 147-153, 2013
112013
Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas
MW Youngblood, D Duran, JD Montejo, C Li, SB Omay, K Özduman, ...
Journal of Neurosurgery 1 (aop), 1-10, 2019
102019
Knockdown of Pin1 leads to reduced angiogenic potential and tumorigenicity in glioblastoma cells
KD Atabay, MT Yildiz, T Avsar, A Karabay, T Kiliç
Oncology letters 10 (4), 2385-2389, 2015
82015
Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay
U Yener, T Avsar, E Akgün, A Şeker, Y Bayri, T Kılıç
Journal of neurosurgery 117 (4), 697-704, 2012
82012
CSF proteomics identifies specific and shared pathways for multiple sclerosis clinical subtypes
T Avsar, İM Durası, U Uygunoğlu, M Tütüncü, NO Demirci, S Saip, ...
PloS one 10 (5), e0122045, 2015
72015
In vivo effect of pregnancy on angiogenesis potential of arteriovenous malformation tissue samples: an experimental study.
D Ceylan, N Tatarli, T Avsar, A Arslanhan, SU Bozkurt, P Bağci, A Seker, ...
Journal of neurosurgical sciences 61 (2), 151-156, 2014
32014
Protein biomarkers of multiple sclerosis: studies of cerebrospinal fluids from clinically different subtypes of MS patients
T Avşar
2*2009
Yüksek gradeli gliomların moleküler biyolojisi
T AVŞAR, T KILIÇ
12017
Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS
J Kuhle, R Dobson, JP Bestwick, J Topping, G Dalla Costa, M Khademi, ...
MULTIPLE SCLEROSIS JOURNAL 19 (11), 33-34, 2013
12013
Proposing novel MDM2 inhibitors: Combined physics‐driven high‐throughput virtual screening and in vitro studies
G Aydin, MN Paksoy, MD Orhan, T Avsar, M Yurtsever, S Durdagi
Chemical Biology & Drug Design 96 (1), 684-700, 2020
2020
Prospective Analysis of Cerebrospinal Fluid Protein Levels Reveals Candidate Biomarkers for Disability Outcome in Multiple Sclerosis (2584)
A Siva, E Everest, U Uygunoglu, D Yavuz, A Bulbul, M Tutuncu, S Saip, ...
Neurology 94 (15 Supplement), 2020
2020
Development of a Rapid and Sensitive IDH1/2 Mutation Detection Method for Glial Tumors and a Comparative Mutation Analysis of 236 Glial Tumor Samples.
T Avsar, A Sursal, G Turan, BN Yigit, D Altunsu, K Cantasir, G Duyu, ...
Molecular Diagnosis & Therapy, 2020
2020
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20